Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
UBS
Farmers Insurance
McKinsey
Dow
Accenture
US Department of Justice
Cantor Fitzgerald
Deloitte

Generated: August 18, 2017

DrugPatentWatch Database Preview

MAGNESIUM SULFATE Drug Profile

« Back to Dashboard

Which patents cover Magnesium Sulfate, and when can generic versions of Magnesium Sulfate launch?

Magnesium Sulfate is a drug marketed by Hospira Inc, Fresenius Kabi Usa, Exela Pharma Scs Llc, Hospira, and Hq Spclt Pharma. and is included in nine NDAs.

The generic ingredient in MAGNESIUM SULFATE is magnesium sulfate. There are one hundred and thirty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.

Summary for Tradename: MAGNESIUM SULFATE

Patents:0
Applicants:5
NDAs:9
Suppliers / Packagers: see list7
Bulk Api Vendors: see list61
Clinical Trials: see list950
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MAGNESIUM SULFATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
MAGNESIUM SULFATE
magnesium sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS202411-001May 14, 2015RXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
MAGNESIUM SULFATE IN PLASTIC CONTAINER
magnesium sulfate
INJECTABLE;INJECTION206485-004Mar 15, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
MAGNESIUM SULFATE
magnesium sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS075151-001Apr 25, 2000APRXNoYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
MAGNESIUM SULFATE
magnesium sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS019316-003Jan 29, 2016RXYesYes► Subscribe► Subscribe► Subscribe
Hospira
MAGNESIUM SULFATE IN PLASTIC CONTAINER
magnesium sulfate
INJECTABLE;INJECTION020309-003Jan 26, 2007APRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
UBS
Merck
Harvard Business School
Mallinckrodt
Federal Trade Commission
US Army
Chubb
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot